Metastatic insulinoma

Metastatic Insulinoma is a rare form of neuroendocrine tumor that originates in the pancreas and spreads (metastasizes) to other parts of the body. These tumors are characterized by the overproduction of insulin, leading to a condition known as hypoglycemia.

Overview

Insulinoma is a type of pancreatic neuroendocrine tumor, which is a rare form of cancer that arises from the islet cells of the pancreas. These tumors are typically small, less than 2 cm in diameter, and are often benign. However, in rare cases, they can metastasize to other parts of the body, such as the liver, and become a metastatic insulinoma.

Symptoms

The symptoms of metastatic insulinoma are primarily due to the overproduction of insulin, which leads to hypoglycemia. These symptoms can include confusion, dizziness, blurred vision, weakness, fatigue, and in severe cases, seizures and loss of consciousness.

Diagnosis

The diagnosis of metastatic insulinoma is typically made through a combination of blood tests, imaging studies, and sometimes, a biopsy of the tumor. Blood tests can reveal low blood sugar levels and high insulin levels, which are indicative of an insulinoma. Imaging studies, such as a CT scan or MRI, can help to locate the tumor and determine if it has spread to other parts of the body.

Treatment

The treatment for metastatic insulinoma typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is often the first line of treatment and involves removing the tumor and any areas of metastasis. Chemotherapy and radiation therapy may be used to shrink any remaining tumors and to help control symptoms.

Prognosis

The prognosis for metastatic insulinoma varies depending on the extent of the disease and the patient's overall health. However, with aggressive treatment, many patients can achieve long-term survival.

See also

• Neuroendocrine tumor
• Pancreatic cancer
• Hypoglycemia